Skip to content
A new research model for biopharma

Biopharma research is no longer a search problem.

The last generation of platforms sold you a database and left the analysis to your team. Mindgram runs the analysis on licensed evidence and hands you the finished work.

A real run, replayed

Watch one objective become the deliverable.

A real Mindgram run. One question in. A finished Excel model and PowerPoint deck out, with every number tied to its source.

Mindgram Real run · 115 min in 45 s
A real session · August 2026

One question in. A finished Excel model and PowerPoint deck out.

Analyst consensusExpert callsClinical evidenceSell-side researchLicensed documents
Ranking the market peak consensus sales, US$bn
  1. 01 Darzalex / Faspro anti-CD38 23.0
  2. 02 Carvykti BCMA CAR-T 6.1
  3. 03 Tecvayli BCMA bispecific 5.7
  4. 04 Anito-cel BCMA CAR-T 3.2
  5. 05 Talvey GPRC5D bispecific 2.9
  6. 06 Zenbexus CELMoD 1.6
  7. 07 ABBV-383 BCMA bispecific 1.4
  8. 08 Sarclisa anti-CD38 1.4
  9. 09 Elrexfio BCMA bispecific 1.3
  10. 10 Kyprolis Proteasome inhibitor 1.3
Researching all ten at once 60 of 60 answered
TrialsDataMRD·OSSafetyLabelNext Darzalex Carvykti Tecvayli Anito-cel Talvey Zenbexus ABBV-383 Sarclisa Elrexfio Kyprolis
Expert calls
BCMA CAR-TBispecificsGPRC5DCD38 frontlineCELMoDsSarclisaABBV-383
Sell-side view
4 assets, 4 analyst questions
Readers wrote up CAR-T: Carvykti vs anito-celBispecifics: four assets comparedGPRC5D, CELMoDs and CD38 dynamicsClinical profiles, all ten drugs
Writing the model and the storyline before anything is built
Workbook model 10 tabs · 370 live formulas
Deck storyline 22 slides, one argument each
House style and QA checklist handed to the builders
Every number tied to a source
224 citations verified

Each figure in the model and the deck is checked against the evidence it came from before a builder ever sees it.

Kyprolis reframed: a generic is approved but blocked, so the decline is displacement, not patent loss.

Building both files each checked before it ships
Excel model
10 tabs, 370 live formulas, every one recalculates clean.
PowerPoint deck
22 slides, zero layout faults, sources on every slide.
Delivered · 1 h 55 min after you asked Request these files →
Title slide: Multiple myeloma, the ten drugs the Street is paying forConsensus grows myeloma by two-thirds, then lets it erodeAnti-CD38 gives up a third of its share; T-cell redirection quadruplesCarvykti vs anito-cel: near-identical efficacy, and one clear safety winnerExperts have already written off the backbone that consensus still pays for
.pptx Multiple myeloma: the ten drugs the Street is paying for
The Ranking tab of the delivered workbook: eleven years of consensus sales for the ten drugs
.xlsx Top 10 by consensus — model, clinical data and expert views
1:54:48 elapsed in the real run

Real session, August 2026. Ten agents working in parallel. Delivered in under two hours. Click a phase to jump.

Request the deck and the model →
The shift

Finding the evidence was never the hard part.

Your team can already pull a trial record or a transcript. What takes three weeks is reading across all of it, reconciling what disagrees, and writing it up so a reviewer can check every number.

The last generation Subscription databases · document search
KRAS G12C · 2L NSCLC · competitive position
1,284 results
Trial record
Press release
Congress abstract
Transcript

You get results, ranked. Reading them, resolving what disagrees and building the deliverable is still an analyst and three weeks.

Mindgram One run
KRAS G12C · 2L NSCLC · competitive position
Planned 6 sections
214 sources screened · 61 included
3 conflicts reconciled
142 claims · 142 cited
[14]

You get the analysis, written up in the format the next person expects, with every claim resolving to its source.

Who we help

Built around the teams that own the decision.

The same evidence base and the same agent, pointed at the work each team actually owes.

All deliverables →
Proof

Measured where it counts.

Mindgram is judged on one thing: whether the deliverable holds up when a reviewer opens the source. Every figure below is a property of the system, not a marketing estimate.

14 evidence classes
100% of claims carry a source
iOS and Android

Mindgram in your pocket.

The full platform on your phone: ask questions, review answers with their sources, and pick up a research session wherever your work takes you.

Ask anything, cited The same evidence base and the same answers, with every source a tap away.
Conference mode Plan the sessions, capture a poster with the camera, and keep it all in one place.
Runs that follow you Start a deep research session at your desk and read the report on the way to the meeting.

Bring a live question. Leave with the deliverable.

Thirty minutes, your asset, your indication. We run it on the call and you keep the output.

Request a demo